Unknown

Dataset Information

0

Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway.


ABSTRACT: Cell therapy using stem cells has produced therapeutic benefits in animal models of COPD. Secretory mediators are proposed as one mechanism for stem cell effects because very few stem cells engraft after injection into recipient animals. Recently, nanovesicles that overcome the disadvantages of natural exosomes have been generated artificially from cells. We generated artificial nanovesicles from adipose-derived stem cells (ASCs) using sequential penetration through polycarbonate membranes. ASC-derived artificial nanovesicles displayed a 100?nm-sized spherical shape similar to ASC-derived natural exosomes and expressed both exosomal and stem cell markers. The proliferation rate of lung epithelial cells was increased in cells treated with ASC-derived artificial nanovesicles compared with cells treated with ASC-derived natural exosomes. The lower dose of ASC-derived artificial nanovesicles had similar regenerative capacity compared with a higher dose of ASCs and ASC-derived natural exosomes. In addition, FGF2 levels in the lungs of mice treated with ASC-derived artificial nanovesicles were increased. The uptake of ASC-derived artificial nanovesicles was inhibited by heparin, which is a competitive inhibitor of heparan sulfate proteoglycan that is associated with FGF2 signaling. Taken together, the data indicate that lower doses of ASC-derived artificial nanovesicles may have beneficial effects similar to higher doses of ASCs or ASC-derived natural exosomes in an animal model with emphysema, suggesting that artificial nanovesicles may have economic advantages that warrant future clinical studies.

SUBMITTER: Kim YS 

PROVIDER: S-EPMC5291836 | biostudies-other | 2017 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway.

Kim You-Sun YS   Kim Ji-Young JY   Cho RyeonJin R   Shin Dong-Myung DM   Lee Sei Won SW   Oh Yeon-Mok YM  

Experimental & molecular medicine 20170113 1


Cell therapy using stem cells has produced therapeutic benefits in animal models of COPD. Secretory mediators are proposed as one mechanism for stem cell effects because very few stem cells engraft after injection into recipient animals. Recently, nanovesicles that overcome the disadvantages of natural exosomes have been generated artificially from cells. We generated artificial nanovesicles from adipose-derived stem cells (ASCs) using sequential penetration through polycarbonate membranes. ASC-  ...[more]

Similar Datasets

| S-EPMC6556631 | biostudies-literature
| S-EPMC7583167 | biostudies-literature
| S-EPMC7716067 | biostudies-literature
| S-EPMC3281333 | biostudies-literature
| S-EPMC8766956 | biostudies-literature
| S-EPMC9265418 | biostudies-literature
| S-EPMC4942136 | biostudies-literature
| S-EPMC3696928 | biostudies-literature
| S-EPMC5342870 | biostudies-literature
| S-EPMC7478378 | biostudies-literature